Source: Novocell, Inc.
Posted: February 20, 2008 3:00 pm ET
Summary:
In an official company news release, Novocell, Inc., a stem cell engineering biotechnology company, reported it successfully turned embryonic stem cells into pancreatic cells that can produce insulin mice:
"announced data demonstrating for the first time that human embryonic stem (hES) cells can be turned into pancreatic cells capable of producing insulin in mice. The findings are reported in an article appearing on-line today, in advance of print publication, in the journal Nature Biotechnology. This research provides evidence supporting the potential future use of hES cells to replace insulin-producing pancreatic cells that are destroyed in people with Type 1 diabetes, requiring them to receive regular insulin treatment."
